Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Jun 24, 2026
Data as of Oct 16
▼ SELL$553K1,003 shares at $551.03Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
- Traded
- Jun 24, 2026
- Disclosed
- Jun 25, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
−1.9%
after the sale
Similar stocks (XLV) since disclosure
+13.5%
XLV — its sector index fund
Change in closing price from Jun 25, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$746Kdisclosed Jun 25 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$415Kdisclosed Jun 25 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$713Kdisclosed Jun 25 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$221Kdisclosed Jun 25 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.1Mdisclosed Jun 25 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.2Mdisclosed Jun 25 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$199Kdisclosed Jun 25 · filed 1 day after the trade